ADMA Biologics, Inc. (ADMA)

17.26 -0.33 (-1.88%) USD  |  NASDAQ  |  Jan 21, 15:50
More

ADMA Biologics Other Receivables (Quarterly)

Other Receivables (Quarterly) Chart

View Other Receivables (Quarterly) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Receivables (Quarterly) Range, Past 5 Years

View Other Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Receivables (Quarterly) Benchmarks

View Other Receivables (Quarterly) Benchmarks
Start Trial
Arcutis Biotherapeutics, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Marker Therapeutics, Inc. --
CorMedix, Inc. Upgrade